Jasper Hellweg
Stock Analyst
(3.53)
# 3,235
Out of 4,648 analysts
87
Total ratings
51.43%
Success rate
5.04%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $376.80 | +6.16% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $153.49 | -2.27% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $52.95 | +13.31% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $828.84 | +41.16% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $472.80 | +16.33% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $71.43 | +19.00% | 3 | May 30, 2024 | |
| NVO Novo Nordisk | Maintains: Buy | $115 → $125 | $109.72 | +13.93% | 1 | Feb 1, 2024 | |
| MRNA Moderna | Maintains: Buy | $160 → $140 | $53.54 | +161.49% | 4 | Sep 13, 2023 | |
| BIIB Biogen | Maintains: Buy | $320 → $350 | $173.52 | +101.71% | 3 | May 11, 2023 | |
| ABBV AbbVie | Downgrades: Hold | n/a | $200.47 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $200 | $175.18 | +14.17% | 6 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $18.64 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $210.19 | +37.97% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $126.54 | -20.97% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $227.17 | +29.86% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.77 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $154.33 | -12.53% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $35.80 | - | 2 | Sep 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $25.41 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $264.69 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $110.22 | - | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $63.57 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $363.16 | -57.32% | 3 | Nov 6, 2018 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $376.80
Upside: +6.16%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $153.49
Upside: -2.27%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $52.95
Upside: +13.31%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $828.84
Upside: +41.16%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $472.80
Upside: +16.33%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $71.43
Upside: +19.00%
Novo Nordisk
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $109.72
Upside: +13.93%
Moderna
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $53.54
Upside: +161.49%
Biogen
May 11, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $173.52
Upside: +101.71%
AbbVie
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $200.47
Upside: -
Jun 17, 2022
Maintains: Buy
Price Target: $225 → $200
Current: $175.18
Upside: +14.17%
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $18.64
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $210.19
Upside: +37.97%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $126.54
Upside: -20.97%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $227.17
Upside: +29.86%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.77
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $154.33
Upside: -12.53%
Sep 4, 2020
Downgrades: Hold
Price Target: n/a
Current: $35.80
Upside: -
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $25.41
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $264.69
Upside: -
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $110.22
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $63.57
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $363.16
Upside: -57.32%